• Home
  • HDAC inhibition potentiates immunotherapy in triple negative breast cancer.

HDAC inhibition potentiates immunotherapy in triple negative breast cancer.

Author List
Terranova-Barberio M, Thomas S, Ali N, Pawlowska N, Park J, Krings G, Rosenblum MD, Budillon A, Munster PN
Publication
Oncotarget
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1411991
Publication Year
2017
PubMed ID
29371976
Publication Title
Terranova-Barberio M, Thomas S, Ali N, Pawlowska N, Park J, Krings G, Rosenblum MD, Budillon A, Munster PN. HDAC inhibition potentiates immunotherapy in triple negative breast cancer. Oncotarget. 2017 Dec 26; 8(69):114156-114172.